Bio-Rad Laboratories Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 14.3 | 19.8 | 10.7 | 24.3 | 12.6 | 18.2 | 14.8 | 19.9 | 22.3 | 21.4 | 21.5 | 30.4 | 23.3 | 18.6 | 15.8 | 15.3 | 17.8 | 45.9 | 39.5 | 36.1 | 192.2 | 62.5 | 19.4 | 6.4 | 4.6 | 5.4 | – | – | – | 10.9 | |
| 0.9 | 0.8 | 0.6 | 0.5 | 0.5 | 1.0 | 1.1 | 1.5 | 1.4 | 1.5 | 1.7 | 1.9 | 1.2 | 1.5 | 1.5 | 1.3 | 1.5 | 1.7 | 1.6 | 2.0 | 2.6 | 3.3 | 3.1 | 4.8 | 6.9 | 7.8 | 4.5 | 3.5 | 3.6 | 3.2 | |
| 2.0 | 1.6 | 1.2 | 1.3 | 1.6 | 2.8 | 2.6 | 3.1 | 2.5 | 2.7 | 2.7 | 2.9 | 2.0 | 2.1 | 1.9 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | 2.1 | 2.4 | 1.7 | 1.9 | 1.8 | 1.7 | 1.3 | 1.1 | 1.4 | 1.1 | |
| 0.9 | 0.8 | 0.6 | 0.5 | 0.8 | 1.2 | 1.2 | 1.7 | 1.6 | 1.6 | 1.9 | 2.1 | 1.3 | 1.6 | 1.5 | 1.4 | 1.6 | 1.7 | 1.6 | 2.0 | 2.6 | 3.3 | 3.1 | 4.8 | 6.7 | 7.7 | 4.8 | 3.8 | 3.9 | 3.5 | |
| 6.5 | 7.0 | 5.0 | 3.8 | 5.4 | 6.2 | 6.1 | 8.9 | 10.1 | 10.6 | 10.6 | 14.2 | 8.6 | 8.3 | 7.6 | 7.1 | 8.1 | 12.1 | 11.6 | 13.5 | 26.1 | 26.8 | 10.4 | 4.5 | 3.3 | 4.0 | – | – | – | 7.2 | |
| 20.8 | – | 42.5 | – | – | 14.3 | 15.8 | 25.9 | 24.3 | 24.1 | 34.1 | 21.9 | 20.3 | 10.8 | 21.9 | 17.1 | 24.7 | 57.8 | 25.7 | 56.0 | 72.5 | – | 45.1 | 31.1 | 36.9 | 42.6 | 156.0 | 43.2 | 34.8 | 22.1 | |
| 4.8% | -10.4% | 2.4% | -65.0% | -1.8% | 7.0% | 6.3% | 3.9% | 4.1% | 4.1% | 2.9% | 4.6% | 4.9% | 9.3% | 4.6% | 5.8% | 4.0% | 1.7% | 3.9% | 1.8% | 1.4% | -0.2% | 2.2% | 3.2% | 2.7% | 2.3% | 0.6% | 2.3% | 2.9% | 4.5% | |
| Margins | ||||||||||||||||||||||||||||||
| 60.8% | 60.2% | 58.9% | 58.6% | 58.7% | 56.4% | 57.1% | 56.3% | 56.0% | 54.7% | 55.9% | 54.2% | 54.6% | 56.0% | 56.6% | 56.8% | 56.1% | 55.3% | 54.2% | 55.5% | 55.0% | 55.0% | 53.5% | 54.4% | 56.5% | 56.1% | 55.9% | 53.4% | 53.7% | 52.0% | |
| 10.0% | 6.2% | 7.0% | 8.8% | 9.2% | 13.7% | 15.4% | 14.5% | 10.0% | 9.8% | 11.5% | 9.3% | 10.4% | 12.9% | 14.7% | 14.2% | 12.8% | 7.9% | 6.9% | 8.3% | 2.6% | 5.4% | -4.7% | 9.9% | 16.6% | 17.1% | 17.2% | 12.6% | 10.5% | 10.5% | |
| 6.3% | 3.8% | 5.5% | 2.1% | 4.3% | 5.4% | 7.6% | 7.6% | 6.3% | 6.9% | 8.1% | 6.4% | 5.1% | 8.1% | 9.6% | 8.6% | 8.2% | 3.6% | 4.1% | 5.6% | 1.4% | 5.3% | 15.8% | 76.1% | 149.8% | 145.6% | -129.5% | -23.9% | -71.9% | 29.4% | |
| 4.3% | -7.9% | 1.4% | -33.7% | -1.0% | 6.9% | 7.1% | 5.8% | 5.7% | 6.1% | 5.1% | 8.8% | 5.8% | 13.9% | 6.9% | 7.7% | 5.9% | 2.9% | 6.3% | 3.6% | 3.6% | -0.5% | 6.8% | 15.5% | 18.7% | 18.3% | 2.9% | 8.2% | 10.4% | 14.5% | |
| Returns | ||||||||||||||||||||||||||||||
| 14.3% | 8.3% | 11.3% | 5.3% | 12.7% | 15.6% | 17.7% | 15.4% | 11.4% | 12.4% | 12.6% | 9.6% | 8.6% | 11.5% | 12.1% | 10.2% | 8.4% | 3.6% | 4.1% | 4.5% | 1.1% | 3.9% | 9.0% | 30.6% | 38.6% | 31.1% | -37.7% | -7.3% | -28.1% | 10.2% | |
| 9.2% | 4.7% | 6.6% | 1.7% | 4.8% | 6.5% | 9.4% | 7.7% | 5.0% | 5.7% | 6.5% | 4.7% | 4.4% | 5.7% | 6.1% | 5.8% | 4.9% | 2.3% | 2.7% | 3.0% | 0.7% | 2.7% | 6.4% | 22.0% | 29.4% | 23.9% | -26.9% | -5.2% | -19.7% | 7.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| -3.8 | 0.0 | -0.7 | 4.9 | 208 | 151 | 86 | 171 | 240 | 132 | 205 | 296 | 251 | 93 | 58 | 158 | 271 | 106 | 23 | -23 | -22 | 51 | 7.9 | -186 | -612 | -423 | 800 | 836 | 755 | 709 | |
| -0.1 | 0.0 | 0.0 | 0.1 | 1.9 | 1.0 | 0.5 | 0.9 | 1.4 | 0.8 | 0.9 | 1.3 | 0.9 | 0.3 | 0.1 | 0.4 | 0.7 | 0.3 | 0.1 | -0.1 | -0.1 | 0.2 | 0.0 | -0.1 | -0.1 | -0.1 | – | – | – | 0.6 | |
| 64.4% | 55.9% | 58.3% | 32.9% | 37.9% | 41.5% | 53.2% | 50.0% | 43.5% | 46.1% | 51.3% | 49.3% | 51.1% | 49.7% | 50.2% | 56.3% | 58.5% | 64.5% | 65.4% | 67.1% | 67.0% | 68.6% | 71.7% | 71.9% | 76.2% | 76.9% | 71.2% | 71.1% | 70.2% | 70.5% | |
| 0.0 | 0.1 | 0.0 | 0.1 | 0.9 | 0.7 | 0.3 | 0.5 | 0.7 | 0.7 | 0.5 | 0.5 | 0.4 | 0.6 | 0.6 | 0.4 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | |
| Per Share | ||||||||||||||||||||||||||||||
| 1.05 | 0.66 | 0.98 | 0.48 | 1.27 | 1.74 | 2.61 | 2.90 | 2.58 | 3.06 | 3.83 | 3.41 | 3.24 | 5.20 | 6.59 | 6.26 | 5.91 | 2.69 | 3.05 | 3.85 | 0.95 | 3.82 | 11.94 | 58.27 | 126.47 | 140.83 | -121.79 | -21.82 | -65.36 | 27.85 | |
| 16.78 | 17.18 | 17.88 | 22.59 | 29.55 | 32.13 | 34.33 | 38.14 | 41.15 | 44.29 | 47.27 | 53.53 | 63.84 | 64.12 | 68.46 | 72.84 | 72.24 | 73.78 | 74.66 | 68.67 | 69.76 | 71.92 | 75.76 | 76.59 | 84.40 | 96.75 | 94.08 | 91.45 | 90.97 | 94.69 | |
| 7.35 | 7.92 | 8.67 | 9.05 | 9.96 | 11.16 | 14.73 | 18.84 | 22.53 | 24.68 | 30.41 | 35.60 | 37.67 | 45.27 | 54.59 | 61.26 | 70.35 | 75.65 | 75.01 | 84.69 | 87.00 | 97.56 | 133.00 | 190.67 | 327.58 | 453.03 | 322.82 | 299.26 | 232.84 | 273.22 | |
| 0.72 | -1.36 | 0.25 | -7.61 | -0.29 | 2.21 | 2.44 | 2.23 | 2.36 | 2.71 | 2.42 | 4.72 | 3.71 | 8.94 | 4.74 | 5.60 | 4.25 | 2.14 | 4.70 | 2.48 | 2.51 | -0.37 | 5.15 | 11.91 | 15.80 | 17.73 | 2.70 | 7.47 | 9.44 | 13.73 | |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.